REALIXIA
Human Osteopontin ELISA Kit Market Value to Reach US$ 539.00 Million by 2034 Amid Rising Biomarker Research
The Human Osteopontin ELISA Kit Market is witnessing steady growth driven by increasing biomedical research activities, rising prevalence of chronic diseases, and growing demand for biomarker-based diagnostic solutions. Osteopontin has emerged as an important biomarker in various research applications involving cancer, cardiovascular disorders, inflammatory diseases, and autoimmune conditions....
189 المشاهدات